LCTX
Lineage Cell Therapeutics Inc
0.9475$
-2.4%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +26.4% | +50.6% | +21.5% | -41.3% | +23.4% | -14.0% | +61.7% | -29.2% | -18.3% | +12.1% | -0.6% | |
| – | +45.8% | -45.7% | +66.2% | -14.7% | +58.2% | -23.5% | +153.5% | -46.2% | -35.9% | +32.7% | +16.0% | |
| – | +43.2% | -47.7% | +66.8% | -36.0% | -59.7% | +243.1% | +71.1% | -79.6% | +212.1% | +29.2% | -10.9% | |
| – | +45.8% | -47.2% | +68.1% | -19.5% | -0.1% | +35.3% | +40.4% | -0.8% | -38.7% | +34.7% | +16.7% | |
| – | +57.9% | -29.7% | +163.3% | +22.1% | +565.2% | -100.0% | +1,278,400.0% | -99.4% | +150.8% | -14.4% | +144.8% | |
| – | -99.6% | – | – | +0.0% | +0.0% | – | – | – | – | – | – | |
| – | +163.8% | -26.7% | +0.1% | +5.5% | +40.1% | -31.1% | -13.5% | +16.4% | – | – | – | |
| – | – | – | – | – | – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -13.5% | -69.6% | -32.4% | -54.7% | +1,443.9% | -2.5% | -0.4% | -0.3% | -0.3% | 0.0% | -31.9% | |
| – | +49.6% | -33.8% | -25.6% | +4.9% | +51.2% | -9.9% | +552.4% | -38.2% | -24.6% | -7.2% | +91.2% | |
| – | +74.8% | -29.0% | -22.3% | -1.0% | -4.7% | +19.6% | +506.5% | -59.7% | -5.4% | -22.2% | -18.7% | |
| – | -24.3% | +752.6% | -67.9% | -15.7% | +298.4% | +5.1% | -35.3% | +14.6% | -7.4% | +30.6% | -26.0% | |
| – | +21.8% | -43.1% | -41.1% | +151.5% | +2.9% | +7.6% | +35.7% | -32.5% | -14.3% | -42.7% | +99.4% | |
| – | +1,114.4% | -76.8% | -98.4% | – | – | – | – | – | – | – | – | |
| – | -26.2% | +338.5% | +37.9% | -42.3% | +20.4% | -14.8% | -4.1% | -20.5% | -13.5% | +23.6% | -43.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +19.9% | +24.9% | +15.0% | +10.9% | +14.7% | +3.1% | +9.6% | +3.2% | +1.7% | +15.9% | +14.9% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.